Publications by authors named "Meghan Diani"

Claim this Profile
A
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?".
Susan F Slovin, Govind Ragupathi, Celina Fernandez, Meghan Diani, Matthew P Jefferson

Cancer Immunol Immunother· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
Susan F Slovin, Govind Ragupathi, Cristina Musselli, Celina Fernandez, Meghan Diani

Cancer Immunol Immunother· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21.
Susan F Slovin, Govind Ragupathi, Celina Fernandez, Matthew P Jefferson, Meghan Diani

Vaccine· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Michael J Morris, Oren Smaletz, David Solit, W Kevin Kelly, Susan Slovin, Meghan Diani

Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis